Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: A prognostic study

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2220-2225

  Hampel, Ori Z ^b   Kattan, Michael W ^b   Yang, Guang ^b   Haidacher, S Joe ^b   Saleh, Georges Y ^b   Thompson, Timothy C ^b   Wheeler, Thomas M ^b   Marcelli, Marco ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Cancer biology; IGF axis; IGFBP 3; Immunocytochemistry; Prostate adenocarcinoma

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROTEIN BINDING; QUANTITATIVE DIAGNOSIS; TREATMENT OUTCOME;

EID: 0032426137     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63309-3     Document Type: Article

References (48)

1. Lamson, G., Giudice, L. C. and Rosenfeld, R. G.: Insulin-like growth factor binding proteins: structural and molecular relationships. Growth Factors, 5: 19, 1991.
2. Mohan, S. and Pettis, J.: Editorial: insulin-like growth factors (IGF)-binding proteins in serum - Do they have additional roles beside modulating the endocrine IGF actions? J. Clin. Endocrinol. Metab., 81: 3821, 1996.
3. Oh, Y., Nagalla, S., Yamanaka, Y. and Rosenfeld, R.: Synthesis and characterization of Insulin-like growth factor binding protein (IGFBP)-7. J. Biol. Chem., 271: 30322, 1996.
4. Kim, H., Nagalla, S., Oh, Y., Wilson, E., Roberts, C. and Rosenfeld, R.: Synthesis and characterization of connective tissue growth factor (CTGF) as insulin-like growth factor in binding protein (IGFBP)-9. Endocrine Society Annual Meeting, Minneapolis, MN, pp. 352, 1997.
5. Lamson, G., Cohen, P., Giudice, L. C., Liu, F., Gargosky, S., Müller, H. L., Oh, Y., Wilson, K. F., Hintz, R. L. and Rosenfeld, R. G.: Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Reg., 3: 91, 1993.
6. Barni, T., Vannelli, B., Sandri, R., Pupilli, C., Ghiandi, P., Rizzo, M., Selli, C., Serio, M. and Fiorelli, G.: Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J. Clin. Endocrinol. Metab., 78: 778, 1994.
7. Cohen, P., Peehl, D. M., Baker, B., Liu, F., Hintz, R. L. and Rosenfeld, R. G.: Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J. Clin. Endocrinol. Metab., 79: 1410, 1994.
8. Tennant, M., Thrasher, J., Twomey, P., Drivdhal, R., Birnbaum, R. and Plymate, S.: Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J. Clin. Endocrinol. Metab., 81: 3774, 1996.
9. Boudon, C., Rodier, G., Lechevallier, E., Mottet, N., Barenton, B. and Sultan, C.: Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J. Clin. Endocrinol. Metab., 81: 612, 1996.
10. Tennant, M., Thrasher, J., Twomey, P., Birnbaum, R. and Plymate, S.: Insulin-like growth factor-binding proteins (IGFBP)-4, -5, -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J. Clin. Endocrinol. Metab., 81: 3783, 1996.
11. Angelloz-Nicoud, P. and Binoux, M.: Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology, 136: 5485, 1995.
12. Figueroa, J., Adrian, V., Jackson, J. and Yee, D.: Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for and IGF-II autocrine growth loop. J. Clin. Endocrinol. Metab., 80: 3476, 1995.
13. Fiorelli, G., de-Bellis, A. D., Longo, A., Giannini, S. and Natali, A.: Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J. Clin. Endocrinol. Metab., 72: 740, 1991.
14. Fiorelli, G., de-Bellis, A., Longo, A., Pioli, P., Costantini, A., Giannini, S., Forti, G. and Serio, M.: Growth factors in the human prostate. J. Steroid Biochem. Mol. Biol., 40: 199, 1991.
15. Cohen, P., Peehl, D., Lamson, G. and Rosenfeld, R. R.: Insulin-like growth factors, IGF receptors and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocrinol. Metab., 73: 401, 1991.
16. Tennant, M., Thrasher, J., Twomey, P., Birnbaum, R. and Plymate, S.: Insulin-like growth factor-binding protein-2 and -3 expression in benign human epithelium, prostate intraepitelial neoplasia, and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab., 81: 411, 1996.
17. Plymate, S., Hwa, V., Thomasini, C., Maddison, L., Trasher, J., Swisshelm, K. and Rosenfeld, R.: Insulin-like growth factor binding protein-7 expression and regulation in the human prostate. Endocrine Society Annual Meeeting, Minneapolis MN, pp. 351, 1997.
18. Macaulay, V. L.: Insulin-like growth factors and cancer. Br. J. Cancer, 65: 311, 1992.
19. Daughaday, W.: Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinol., 127: 1, 1990.
20. Baserga, R.: The insulin-like growth factor I receptor: a key to tumor growth?, Cancer Res., 55: 249, 1995.
21. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K. and Hintz, R.: Altered body and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem., 269: 13779, 1994.
22. D'Ambrosio, C., Ferber, A., Resnicoff, M. and Baserga, R.: A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013, 1995.
23. LeRoith, D., Baserga, R., Helman, L. and Roberts, C.: Insulin-like growth factors and cancers. Ann. Intern. Med., 122: 54, 1995.
24. Pekonen, F., Nyman, T., Ilvesmaki, V. and Partanen, S.: Insulin-like growth factor binding proteins in human breast cancer. Cancer Res., 52: 5204, 1992.
25. Figueroa, J. A., Jackson, J. G., McGuire, W. L., Krywicki, R. F. and Yee, D.: Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J. Cell. Biochem., 52: 196, 1993.
26. Reeve, J. G., Morgan, J., Schwander, J. and Bleehen, N. M.: Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Cancer Res., 53: 4680, 1993.
27. Rutanen, E. M., Nyman, T., Lehtovirta, P., Ammala, M. and Pekonen, F.: Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors, Int. J. Cancer, 59: 307, 1994.
28. Unterman, T. G., Glick, R. P., Waites, G. T. and Bell, S. C.: Production of insulin-like growth factor binding proteins by human central nervous system tumors. Cancer Res., 51: 3030, 1991.
29. Flyvbjerg, A., Mogensen, O., Mogensen, B. and Nielsen, O.: Elevated serum insulin-like growth factor binding protein-2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor associated trypsin inhibitor, J. Clin. Endocrinol. Metab., 82: 2308, 1997.
30. Thrasher, J., Tennant, M., Twomey, P., Hansberry, K., Wettlaufer, J. and Plymate, S.: Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations. J. Urol., 155: 999, 1996.
31. Cohen, P., Peehl, D. M., Graves, H. C. B. and Rosenfeld, R. G.: Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142: 407, 1994.
32. Kaicer, E., Blat, C., Imbenotte, J., Troalen, F., Cussenot, O., Calvo, F. and Harel, L.: IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC3): differential effect on PC-3 and normal prostate cell growth. Growth Reg., 3: 180, 1993.
33. Oh, Y., Müller, H., Ng, L. and Rosenfeld, R.: Transforming growth factor-b-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem., 270: 13589, 1995.
34. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. and Kley, N.: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature, 377: 646, 1995.
35. Gucev, Z., Oh, Y., Kelley, K. and Rosenfeld, R.: Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res., 56: 1545, 1996.
36. Velez-Yanguas, M., Kalebic, T., Maggi, M., Kappel, C. C., Letterio, J., Uskokovic, M. and Helman, L.: 1α,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line. J. Clin. Endocrinol. Metab., 81: 93, 1996.
37. Kanety, H., Madjar, Y., Dagan, Y., Levi, J., Papa, M. Z., Pariente, C., Goldwasser, B. and Karasik, A.: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77: 229, 1993.
38. Rajah, R., Valentinis, B. and Cohen, P.: Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem., 272: 12181, 1997.
39. Sommer, A., Maack, C., Spratt, S., Mascarehans, D., Tressel, T., Rhodes, E., Lee, R., Roumas, M., Tatsuno, G., Flynn, J., Gerber, N., Taylor, J., Cudny, H., Nanney, L., Hunt, T. and Spencer, E.: Molecular genetics of recombinant insulin-like growth factor binding protein-3. In: Modern Concept of Insulin-Like Growth Factors. Edited by E. Spencer, pp. 715-728. New York: Elsevier, 1991.
40. Littell, R., Milliken, G., Stroup, W. and Walfinger, R.: SAS System for Mixed Models. Cary, NC: SAS Institute Inc, 1996.
41. Rosenfeld, R., Lamson, G., Pham, H., Oh, Y., Conover, C., DeLeon, D., Donovan, S., Ocrant, I. and Giudice, L.: Insulin-like growth factor binding proteins. Recent Prog. Horm. Res., 46: 99, 1990.
42. Valentini, B., Bhala, A., DeAngelis, T., Baserga, R. and Cohen, P.: The human insulin-like growth factor(IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol., 9: 361, 1995.
43. Cohen, P., Graves, H. C. B., Peehl, D. M., Kamarei, M., Giudice, L. C. and Rosenfeld, R. G.: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab., 75: 1046, 1992.
44. Fowlkes, J. L., Enghild, J. J., Suzuki, K. and Nagase, H.: Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem., 269: 25742, 1994.
45. Conover, C. A., Perry, J. E. and Tindall, D. J.: Endogenous cathepsin-D mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J. Clin. Endocrinol. Metab., 80: 987, 1995.
46. Stearns, M. and Stearns, M.: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878, 1993.
47. Maygarden, S. J., Novotny, D. B., Moul, J. W., Bae, V. L. and Ware, J. L.: Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod. Pathol., 7: 930, 1994.
48. Makar, R., Mason, A., Kittelson, J. M., Bowden, G. T., Cress, A. E. and Nagel, R. A.: Immunohistochemical analysis of cathepsin D in prostate carcinoma. Mod. Pathol., 7: 747, 1994.